Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment (WalkCog-MCI)

September 21, 2022 updated by: Pennington Biomedical Research Center
The purpose of this study is to determine the effects of a coordinated intervention of cognitive remediation training (CRT) and walking intervention on cognition and gait in the elderly.

Study Overview

Detailed Description

This is a single blind randomized study designed to understand the effects of different interventions, walking interventions and cognitive remediation in particular, towards cognition and gait in the elderly. The study uses a 4 arm approach consisting of 4 intervention groups, with each intervention lasting for 12 weeks. The investigators will investigate the effect of each intervention towards cognitive function and gait. All interventions will be conducted on site at the Pennington Biomedical Research Center, and will be focused on determining the effects of different combinations of walking, cognitive remediation, healthy living courses, and reading. Cognitive measures will include objective clinical measures related to dementia, and the gait analysis will include in clinic and "free living" measures related to falls.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Louisiana
      • Baton Rouge, Louisiana, United States, 70808
        • Pennington Biomedical Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women meeting all criteria listed below will be included in the study:
  • Subjects between 65-85 years of age inclusive
  • Subjects with Short Physical Performance Battery of 10 or greater
  • Subjects averaging less than 5,000 steps per day
  • Subjects with Mini Mental State Exam 25-28, inclusive
  • Subjects with normal for age physical-neurological exam
  • Subjects able to walk a city block without a walking aid
  • Written Informed Consent obtained PRIOR to performing any study procedures

Exclusion Criteria:

  • Subjects with difficult walking due to pain or posture
  • Subjects with difficulty in using computer due to significant visual and/or fine motor impairment
  • Subjects with large weight loss (>15 Kilogram) in the last 12 months
  • Subjects with geriatric depression scale > 9.
  • Subjects with Malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled
  • Subjects with abnormal electrocardiogram results. These include: a resting heart rate below 40 bpm or above 100 bpm, previously unknown and/or untreated atrial fibrillation or flutter, evidence of a third degree A-V block, a previously undocumented left bundle branch block, S-T segment depression of greater than 2 mm, evidence of a previous MI, or any other findings that in the clinical judgment of the medical investigator preclude participation in an exercise intervention.
  • Subjects with shortness of breath, exertional angina, uncontrolled high blood pressure or any other chronic medical condition deemed by the physician to preclude participation in an exercise intervention.
  • Subjects with any other medical condition or disease that is life-threatening or that can interfere with, or be aggravated by, exercise.
  • Subjects who currently smoke.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Remediation Therapy Group
30 minute Cognitive Remediation Therapy and 60 minute Healthy Living Class three time per week
30 min Cognitive Remediation Therapy + 60 Min Healthy Living class 3x week
Experimental: Walking Intervention Group
60 minutes of walking and 30 minutes of reading stimulation three times a week
60 min Walking Intervention + 30 min low interface reading 3x week
Experimental: Combination Group
30 minutes of Cognitive Remediation therapy and 60 minutes of walking three times a week
30 min Cognitive Remediation Therapy + 60 min Walking Intervention 3x week
Experimental: Healthy Living Group
60 minute Healthy Living Class and 30 minutes of reading stimulation three times a week.
60 Min Healthy Living class + 30 min low interface reading 3x week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of interventions on cognition
Time Frame: 6 months
Standard psychometric tests will be used to measure cognition
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of interventions on gait
Time Frame: 6 months
Standard laboratory assessments and accelerometers will be used to measure gait.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey Keller, PhD, Pennington Biomedical Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

February 26, 2013

First Submitted That Met QC Criteria

February 27, 2013

First Posted (Estimate)

March 1, 2013

Study Record Updates

Last Update Posted (Actual)

September 23, 2022

Last Update Submitted That Met QC Criteria

September 21, 2022

Last Verified

June 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • PBRC 12032

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Cognitive Remediation Therapy Group

Subscribe